Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw Purchases 21,142 Shares

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw purchased 21,142 shares of the firm’s stock in a transaction dated Wednesday, October 23rd. The shares were bought at an average price of $0.74 per share, with a total value of $15,645.08. Following the purchase, the chief executive officer now owns 14,794,794 shares in the company, valued at $10,948,147.56. This represents a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Retractable Technologies Price Performance

Shares of NYSE:RVP opened at $0.73 on Friday. The business has a 50 day moving average price of $0.85 and a 200 day moving average price of $1.00. Retractable Technologies, Inc. has a twelve month low of $0.71 and a twelve month high of $1.34. The company has a market cap of $21.93 million, a price-to-earnings ratio of -2.82 and a beta of 2.06. The company has a quick ratio of 6.54, a current ratio of 9.51 and a debt-to-equity ratio of 0.01.

Retractable Technologies (NYSE:RVP) last posted its quarterly earnings results on Wednesday, August 14th. The company reported ($0.48) EPS for the quarter. The firm had revenue of $6.03 million during the quarter. Retractable Technologies had a negative net margin of 46.72% and a negative return on equity of 18.67%.

Hedge Funds Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC bought a new position in Retractable Technologies, Inc. (NYSE:RVP) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies at the end of the most recent quarter. 7.58% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, StockNews.com started coverage on Retractable Technologies in a research note on Friday, October 18th. They set a “hold” rating for the company.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.